SESSION TITLE: COPD I
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: To investigate the clinical value and significance of fractional exhaled nitric oxide (FeNO) in patients with chronic obstructive pulmonary disease (COPD).
METHODS: A total of 67 outpatients, including 35 cases with acute exacerbation of COPD and 32 cases with acute exacerbation of bronchial asthma, were recruited from the Department of Respiratory Medicine, The Second People’s Hospital of Zhengzhou (Zhengzhou, Henan, China), from September 2013 to February 2015. COPD or asthma was separately diagnosed according to the Global Initiative for Chronic Obstructive Disease (GOLD) criteria or the Global Institute for Asthma guidelines. Current smokers or patients who regularly take oral corticosteroid for at least one month were excluded from the study for fear of influence. According to the current guidelines (American Thoracic Society/European Respiratory Society, ATS/ERS, 2005), FeNO levels were measured by using nitric oxide analyzer and serum C-reactive protein (CRP), peripheral blood eosinophil rate (EOS%), pulmonary functions were also detected at the same time for all patients. Data were analyzed by the statistical package of social science(SPSS) for Windows, version 19.0 (SPSS Inc. USA IBM).